Status:
NOT_YET_RECRUITING
Shared Decision Making for Antipsychotic Medications
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
Temple University
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
This study aims to provide an evidence-based shared decision making intervention for antipsychotic medications, the Antipsychotic Medication Decision Aid (APM-DA), for individuals experiencing early p...
Detailed Description
The investigators will conduct a cluster RCT of the APM-DA intervention at 6 OnTrackNY clinics, with 3 clinics implementing APM-DA as part of their psychiatric visits and 3 randomized to serve as cont...
Eligibility Criteria
Inclusion
- Ages 18 to 30 who have experienced nonaffective psychosis with a diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder, other specified/unspecified schizophrenia spectrum and other psychotic disorders (ICD-10-CM Diagnosis Code F20.x)
- Current/past experiences with antipsychotic medications (APM; e.g., currently taking any antipsychotic medication, stopped taking, or considering stopping).
- Receive FEP treatment in one of OnTrackNY clinics/sites randomized to intervention or treatment as usual (TAU) - Willing to participate in research interviews after each APM visit during the study period (3 months)
Exclusion
- Unable to provide informed consent
- No experience with APM
- Not fluent (speaking, reading, writing) in English
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05416658
Start Date
January 1 2026
End Date
June 30 2026
Last Update
March 20 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.